- Bedoelde u
- hospitalisation
Zoekresultaten - 49 results
Influenza versus other respiratory viruses – assessing severity among hospitalised children, Belgium, 2011 to 2020.
Publication Type: Peer reviewed scientific article Authors: Fischer, Natalie; S Moreels; Dauby, Nicolas; Reynders, Marijke; Petit, Evelyn; Gerard, Michèle; Lacor, Patrick; Daelemans, Siel; Lissoir, Bénédicte; Holemans, Xavier; Magerman, Koen; Jouck, Door; ...
Multinational collaboration in solving a European Braenderup outbreak linked to imported melons, 2021.
Braenderup outbreak cases (n = 348) had been reported from 12 countries in the European Union/European Economic Area (EU / EEA) and the United Kingdom (UK), including 68 hospitalised cases. With support from ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Publication Type: Peer reviewed scientific article Authors: Rose, Angela MC; Nicolay, Nathalie; Sandonis Martín, Virginia; Mazagatos, Clara; Petrović, Goranka; Niessen, F Annabel; Machado, Ausenda; Launay, Odile; Sarah Denayer; Seyler, Lucie; Baruch, Joaq ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Publication Type: Peer reviewed scientific article Authors: Rose, Angela MC; Nicolay, Nathalie; Sandonis Martín, Virginia; Mazagatos, Clara; Petrović, Goranka; Baruch, Joaquin; Sarah Denayer; Seyler, Lucie; Domegan, Lisa; Launay, Odile; Machado, Ausenda; ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Humans REGISTRIES Vaccine Efficacy Abstract: BACKGROUND: Within the ECDC- VEBIS project, we prospectively monitored vaccine effectiveness (VE) against COVID-19 hospitalisation and COVID-19-related death ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
SARS-CoV-2 in hospitalised severe acute respiratory illness (SARI) patients ≥ 20 years, combining data from these networks during Alpha (March-June)- and Delta (June-December)-dominant periods, ...
Aetiological and prognostic roles of frailty, multimorbidity and socioeconomic characteristics in the development of SARS-CoV-2 health outcomes: protocol for systematic reviews of population-based studies
infection probability, hospitalisation, intensive care unit (ICU) admission, mechanical ventilation and COVID-19 related mortality among general population and (2) to investigate the prognostic roles of ...
A comparison of COVID-19 incidence rates across six European countries in 2021.
such as death or hospitalisation will be important to improving international comparisons. Health Topics: Coronavirus Coronavirus Coronavirus Service: Épidémiologie des maladies infectieuses ...
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
hospitalisation (VE h), given time since vaccination and prior infection.MethodsNationwide healthcare records from July 2021 to May 2022 on testing and vaccination were combined with a clinical hospital survey. We ...